LVTX Valuation

LAVA Therapeutics NV (LVTX) has a current Price-to-Book (P/B) ratio of 3.61. Compared to its 3-year average P/B ratio of 1.18 , the current P/B ratio is approximately 205.97% higher. Relative to its 5-year average P/B ratio of 1.22, the current P/B ratio is about 195.54% higher. LAVA Therapeutics NV (LVTX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -45.22%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -37.64% , the current FCF yield is about -100.00% lower.